Cardiologists and sub-specialists will have an opportunity to learn about the latest developments in the diagnosis and treatment of atrial fibrillation at a Heart Rhythm Society (HRS) Complementary CME Satellite Symposium on Thursday, May 13 at the Hyatt Regency Denver. The program, “Coming to Consensus: Defining New Treatment and Management Options for Atrial Fibrillation,” is hosted by the University of Utah School of Medicine and sponsored by an educational grant from eCardio Diagnostics.

Topics covered at the symposium, which will take place from 6:30 p.m. to 9:30 p.m., will include:
• Can ambulatory cardiac monitoring be used to prevent anti-coagulation in AF patients?
• Is there a role for complex fractionated electrograms in the management of AF?
• What are the endpoints of AF ablation procedures?
• MRI for AF management: How can this be used to follow disease progression and define optimal treatment?

Francis Marchlinski, MD, Director of the Cardiac Electrophysiology and Professor of Medicine at the University of Pennsylvania Health System, and Douglas Packer, MD, Director of Heart Rhythm Services at the Mayo Clinic are the moderators for this event, and I am honored to serve as the director. Other symposium speakers will include expert physicians from the University of Michigan, Johns Hopkins University and the University of Virginia.

Physicians who attend this educational activity can earn a maximum of 2 AMA PRA Category 1 Credits™. The symposium complements but is not part of the Heart Rhythm 2010 Official Scientific Session.

For more information, including how to register, visit the Symposium website at http://test.healthsciences.utah.edu/carma/HRS.html.

I’ll share highlights from this symposium in my June blog post.

Nassir F. Marrouche, MD is the Executive Director of the Comprehensive Arrhythmia Research & Management Center, Director of Electrophysiology Laboratories, and Director of the Atrial Fibrillation Program at the University of Utah School of Medicine, Division of Cardiology.